2023-03-19 02:02:19 ET
Summary
- KIDS expects its top line expansion to slow in the current year, due to pediatric hospitals' staffing challenges and the potential deferral of elective surgeries.
- On the other hand, OrthoPediatrics' recent acquisitions and its differentiated strategy of targeting young surgeons point to a promising growth outlook for KIDS in the mid to long term.
- I assign a Hold rating to KIDS stock; investors shouldn't be hasty in building a position in OrthoPediatrics' shares, as the company is expected to witness revenue growth deceleration in 2023.
For further details see:
OrthoPediatrics: Patience Is Required